PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects
Breast cancer is a serious health problem worldwide, representing the second cause of
death through malignancies among women in developed countries. Population …
death through malignancies among women in developed countries. Population …
Epidemiological characteristics of and risk factors for breast cancer in the world
Z Momenimovahed, H Salehiniya - Breast Cancer: Targets and …, 2019 - Taylor & Francis
Aim Breast cancer is the most common cancer among women and one of the most important
causes of death among them. This review aimed to investigate the incidence and mortality …
causes of death among them. This review aimed to investigate the incidence and mortality …
Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies
MI Nounou, F ElAmrawy, N Ahmed… - Breast cancer: basic …, 2015 - journals.sagepub.com
Breast cancer is the most prevalent cancer among women worldwide. However, increased
survival is due to the dramatic advances in the screening methods, early diagnosis, and …
survival is due to the dramatic advances in the screening methods, early diagnosis, and …
Mining electronic health records (EHRs) A survey
The continuously increasing cost of the US healthcare system has received significant
attention. Central to the ideas aimed at curbing this trend is the use of technology in the form …
attention. Central to the ideas aimed at curbing this trend is the use of technology in the form …
Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology
WJ Gradishar, BO Anderson, R Balassanian… - Journal of the National …, 2016 - jnccn.org
Breast cancer is the most common malignancy in women in the United States and is second
only to lung cancer as a cause of cancer death. The overall management of breast cancer …
only to lung cancer as a cause of cancer death. The overall management of breast cancer …
European academy of andrology guidelines on Klinefelter syndrome endorsing organization: European Society of Endocrinology
M Zitzmann, L Aksglaede, G Corona, AM Isidori… - …, 2021 - Wiley Online Library
Abstract Background Knowledge about Klinefelter syndrome (KS) has increased
substantially since its first description almost 80 years ago. A variety of treatment options …
substantially since its first description almost 80 years ago. A variety of treatment options …
Breast carcinoma in men: a population‐based study
SH Giordano, DS Cohen, AU Buzdar… - … Journal of the …, 2004 - Wiley Online Library
BACKGROUND Male breast carcinoma is an uncommon disease, and most previous
studies have been single‐institution series that were limited by extremely small sample …
studies have been single‐institution series that were limited by extremely small sample …
Multidisciplinary meeting on male breast cancer: summary and research recommendations
LA Korde, JA Zujewski, L Kamin, S Giordano… - Journal of clinical …, 2010 - ascopubs.org
Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …
Male breast cancer: a population-based comparison with female breast cancer
WF Anderson, I Jatoi, J Tse… - Journal of Clinical …, 2010 - ascopubs.org
Purpose Because of its rarity, male breast cancer is often compared with female breast
cancer. Patients and Methods To compare and contrast male and female breast cancers, we …
cancer. Patients and Methods To compare and contrast male and female breast cancers, we …
FDA approval summary: palbociclib for male patients with metastatic breast cancer
S Wedam, L Fashoyin-Aje, E Bloomquist, S Tang… - Clinical Cancer …, 2020 - AACR
Abstract On April 4, 2019, the FDA approved a supplemental new drug application for
palbociclib (IBRANCE), to expand the approved indications in women with hormone …
palbociclib (IBRANCE), to expand the approved indications in women with hormone …